These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
588 related articles for article (PubMed ID: 24424512)
21. MiR-340 impedes the progression of laryngeal squamous cell carcinoma by targeting EZH2. Yu W; Zhang G; Lu B; Li J; Wu Z; Ma H; Wang H; Lian R Gene; 2016 Feb; 577(2):193-201. PubMed ID: 26656176 [TBL] [Abstract][Full Text] [Related]
22. Polycomb repressive complex 2 and its core component EZH2: potential targeted therapeutic strategies for head and neck squamous cell carcinoma. Cheng Y; Song Z; Fang X; Tang Z Clin Epigenetics; 2024 Apr; 16(1):54. PubMed ID: 38600608 [TBL] [Abstract][Full Text] [Related]
23. LINC00662 Promotes Oral Squamous Cell Carcinoma Cell Growth and Metastasis through miR-144-3p/EZH2 Axis. Yao Y; Liu Y; Jin F; Meng Z Yonsei Med J; 2021 Jul; 62(7):640-649. PubMed ID: 34164962 [TBL] [Abstract][Full Text] [Related]
24. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance. Su L; Wang Y; Xiao M; Lin Y; Yu L Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995 [TBL] [Abstract][Full Text] [Related]
25. EZH2-mediated upregulation of ROS1 oncogene promotes oral cancer metastasis. Shih CH; Chang YJ; Huang WC; Jang TH; Kung HJ; Wang WC; Yang MH; Lin MC; Huang SF; Chou SW; Chang E; Chiu H; Shieh TY; Chen YJ; Wang LH; Chen L Oncogene; 2017 Nov; 36(47):6542-6554. PubMed ID: 28759046 [TBL] [Abstract][Full Text] [Related]
26. Role of the EZH2/miR-200 axis in STAT3-mediated OSCC invasion. Wang Y; Guo W; Li Z; Wu Y; Jing C; Ren Y; Zhao M; Kong L; Zhang C; Dong J; Shuang Y; Sun S; Chen J; Wu C; Qiao Y; Qu X; Wang X; Zhang L; Jin R; Zhou X Int J Oncol; 2018 Apr; 52(4):1149-1164. PubMed ID: 29532870 [TBL] [Abstract][Full Text] [Related]
27. Knocking-down of CREPT prohibits the progression of oral squamous cell carcinoma and suppresses cyclin D1 and c-Myc expression. Ma J; Ren Y; Zhang L; Kong X; Wang T; Shi Y; Bu R PLoS One; 2017; 12(4):e0174309. PubMed ID: 28369091 [TBL] [Abstract][Full Text] [Related]
28. Up-regulation of miR-187 modulates the advances of oral carcinoma by targeting BARX2 tumor suppressor. Lin SC; Kao SY; Chang JC; Liu YC; Yu EH; Tseng SH; Liu CJ; Chang KW Oncotarget; 2016 Sep; 7(38):61355-61365. PubMed ID: 27542258 [TBL] [Abstract][Full Text] [Related]
29. MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2. Zhang JG; Guo JF; Liu DL; Liu Q; Wang JJ J Thorac Oncol; 2011 Apr; 6(4):671-8. PubMed ID: 21270667 [TBL] [Abstract][Full Text] [Related]
30. Inhibition of enhancer of zeste homolog 2 (EZH2) expression is associated with decreased tumor cell proliferation, migration, and invasion in endometrial cancer cell lines. Eskander RN; Ji T; Huynh B; Wardeh R; Randall LM; Hoang B Int J Gynecol Cancer; 2013 Jul; 23(6):997-1005. PubMed ID: 23792601 [TBL] [Abstract][Full Text] [Related]
31. Enhancer of zeste homolog 2 (EZH2) promotes progression of cholangiocarcinoma cells by regulating cell cycle and apoptosis. Nakagawa S; Okabe H; Sakamoto Y; Hayashi H; Hashimoto D; Yokoyama N; Sakamoto K; Kuroki H; Mima K; Nitta H; Imai K; Chikamoto A; Watanabe M; Beppu T; Baba H Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S667-75. PubMed ID: 23887863 [TBL] [Abstract][Full Text] [Related]
32. Enhancer of zeste homolog 2 silences microRNA-218 in human pancreatic ductal adenocarcinoma cells by inducing formation of heterochromatin. Li CH; To KF; Tong JH; Xiao Z; Xia T; Lai PB; Chow SC; Zhu YX; Chan SL; Marquez VE; Chen Y Gastroenterology; 2013 May; 144(5):1086-1097.e9. PubMed ID: 23395645 [TBL] [Abstract][Full Text] [Related]
33. LncRNA, TUG1 regulates the oral squamous cell carcinoma progression possibly via interacting with Wnt/β-catenin signaling. Liang S; Zhang S; Wang P; Yang C; Shang C; Yang J; Wang J Gene; 2017 Apr; 608():49-57. PubMed ID: 28119088 [TBL] [Abstract][Full Text] [Related]
34. Decreased microRNA-143 expression and its tumor suppressive function in human oral squamous cell carcinoma. Ni ZY; Lin FO; Liu DF; Xiao J Genet Mol Res; 2015 Jun; 14(2):6943-52. PubMed ID: 26125902 [TBL] [Abstract][Full Text] [Related]
35. Yin Yang 1-Induced Long Noncoding RNA DUXAP9 Drives the Progression of Oral Squamous Cell Carcinoma by Blocking CDK1-Mediated EZH2 Degradation. Zhou W; Feng Y; Lin C; Chao CK; He Z; Zhao S; Xue J; Zhao XY; Cao W Adv Sci (Weinh); 2023 Sep; 10(25):e2207549. PubMed ID: 37401236 [TBL] [Abstract][Full Text] [Related]
36. Overexpression of angiopoietin 2 promotes the formation of oral squamous cell carcinoma by increasing epithelial-mesenchymal transition-induced angiogenesis. Li C; Li Q; Cai Y; He Y; Lan X; Wang W; Liu J; Wang S; Zhu G; Fan J; Zhou Y; Sun R Cancer Gene Ther; 2016 Sep; 23(9):295-302. PubMed ID: 27492854 [TBL] [Abstract][Full Text] [Related]
37. NCAPD2 promotes the malignant progression of oral squamous cell carcinoma via the Wnt/β-catenin pathway. Ma P; Yu H; Zhu M; Liu L; Cheng L; Han Z; Jin W Cell Cycle; 2024 Mar; 23(5):588-601. PubMed ID: 38743408 [TBL] [Abstract][Full Text] [Related]
38. GALNT2 enhances migration and invasion of oral squamous cell carcinoma by regulating EGFR glycosylation and activity. Lin MC; Huang MJ; Liu CH; Yang TL; Huang MC Oral Oncol; 2014 May; 50(5):478-84. PubMed ID: 24582885 [TBL] [Abstract][Full Text] [Related]
39. Tumor protein D54 is a negative regulator of extracellular matrix-dependent migration and attachment in oral squamous cell carcinoma-derived cell lines. Mukudai Y; Kondo S; Fujita A; Yoshihama Y; Shirota T; Shintani S Cell Oncol (Dordr); 2013 Jun; 36(3):233-45. PubMed ID: 23529586 [TBL] [Abstract][Full Text] [Related]
40. Increased levels of the long intergenic non-protein coding RNA POU3F3 promote DNA methylation in esophageal squamous cell carcinoma cells. Li W; Zheng J; Deng J; You Y; Wu H; Li N; Lu J; Zhou Y Gastroenterology; 2014 Jun; 146(7):1714-26.e5. PubMed ID: 24631494 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]